Megan N. Frone

781 total citations
11 papers, 175 citations indexed

About

Megan N. Frone is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Megan N. Frone has authored 11 papers receiving a total of 175 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Megan N. Frone's work include Cancer Genomics and Diagnostics (6 papers), Cancer-related Molecular Pathways (6 papers) and BRCA gene mutations in cancer (2 papers). Megan N. Frone is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Cancer-related Molecular Pathways (6 papers) and BRCA gene mutations in cancer (2 papers). Megan N. Frone collaborates with scholars based in United States, France and Slovakia. Megan N. Frone's co-authors include Sharon A. Savage, Kelvin C. de Andrade, Pierre Hainaut, Payal P. Khincha, Douglas R. Stewart, William J.R. Longabaugh, Lei Zhou, James J. Manfredi, Chimene Kesserwan and David Malkin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cell Death and Differentiation.

In The Last Decade

Megan N. Frone

10 papers receiving 173 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Megan N. Frone United States	6	97	86	64	44	18	11	175
Ewa A. Bergmann United States	3	40 0.4×	98 1.1×	77 1.2×	48 1.1×	36 2.0×	3	177
Michael P. Randall United States	7	81 0.8×	119 1.4×	54 0.8×	20 0.5×	18 1.0×	11	215
Freek Manders Netherlands	8	44 0.5×	122 1.4×	114 1.8×	33 0.8×	39 2.2×	14	202
Monika Kowal Poland	9	53 0.5×	141 1.6×	53 0.8×	22 0.5×	23 1.3×	15	258
Jianjun Xiao China	9	115 1.2×	89 1.0×	75 1.2×	24 0.5×	13 0.7×	16	222
Mariko Tabata Japan	5	47 0.5×	77 0.9×	49 0.8×	13 0.3×	11 0.6×	12	148
Agnieszka Timorek Poland	9	92 0.9×	109 1.3×	55 0.9×	36 0.8×	38 2.1×	19	258
Yannick Boursin France	6	69 0.7×	75 0.9×	67 1.0×	38 0.9×	29 1.6×	9	190
Kelly M. Arcipowski United States	7	102 1.1×	102 1.2×	53 0.8×	13 0.3×	56 3.1×	7	250
Peterson Kariuki Maina United States	7	100 1.0×	231 2.7×	69 1.1×	22 0.5×	9 0.5×	7	351

Countries citing papers authored by Megan N. Frone

Since Specialization

Citations

This map shows the geographic impact of Megan N. Frone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan N. Frone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan N. Frone more than expected).

Fields of papers citing papers by Megan N. Frone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan N. Frone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan N. Frone. The network helps show where Megan N. Frone may publish in the future.

Co-authorship network of co-authors of Megan N. Frone

This figure shows the co-authorship network connecting the top 25 collaborators of Megan N. Frone. A scholar is included among the top collaborators of Megan N. Frone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan N. Frone. Megan N. Frone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Nehoray, Bita, et al.. (2024). P091: Variants at variance: An assessment of discordant classifications and phenotypes among TP53 variants from the international LiFT UP study. SHILAP Revista de lepidopterología. 2. 100972–100972. 1 indexed citations

Andrade, Kelvin C. de, et al.. (2023). Spectrum and Excess Risk of Gastrointestinal Tumors in Li-Fraumeni Syndrome. Clinical Gastroenterology and Hepatology. 22(3). 662–665.e1. 1 indexed citations

Andrade, Kelvin C. de, Natasha T. Strande, Jung Kim, et al.. (2023). Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants. Human Genetics and Genomics Advances. 5(1). 100242–100242. 6 indexed citations

Andrade, Kelvin C. de, Chimene Kesserwan, James J. Manfredi, et al.. (2022). The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute. Cell Death and Differentiation. 29(5). 1071–1073. 80 indexed citations

Sargen, Michael R., et al.. (2022). Spectrum and Incidence of Skin Cancer among Individuals with Li-Fraumeni Syndrome. Journal of Investigative Dermatology. 142(9). 2534–2537.e1. 3 indexed citations

Frone, Megan N., Douglas R. Stewart, Sharon A. Savage, & Payal P. Khincha. (2021). Quantification of Discordant Variant Interpretations in a Large Family-Based Study of Li-Fraumeni Syndrome. JCO Precision Oncology. 5(5). 1727–1737. 6 indexed citations

Shao, Kang, Lusheng Wang, Christian S. Álvarez, et al.. (2021). Germline variants in hereditary breast cancer genes are associated with early age at diagnosis and family history in Guatemalan breast cancer. Breast Cancer Research and Treatment. 189(2). 533–539. 6 indexed citations

Best, Ana F., Margaret A. Tucker, Megan N. Frone, et al.. (2019). A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of BRCA1/2. Cancer Epidemiology Biomarkers & Prevention. 28(2). 293–302. 4 indexed citations

Morton, Lindsay M., Danielle M. Karyadi, Megan N. Frone, et al.. (2019). Subsequent neoplasm risk associated with rare variants in DNA repair and clinical radiation sensitivity syndrome genes: A report from the Childhood Cancer Survivor Study.. Journal of Clinical Oncology. 37(15_suppl). 10028–10028.

10.

Andrade, Kelvin C. de, Megan N. Frone, Talía Wegman-Ostrosky, et al.. (2018). Variable population prevalence estimates of germline TP53 variants: A gnomAD-based analysis. Human Mutation. 40(1). 97–105. 62 indexed citations

11.

Isaacson, Brandon, Petra Bullova, Megan N. Frone, et al.. (2015). AN AGGRESSIVE TEMPORAL BONE SDHC PARAGANGLIOMA ASSOCIATED WITH INCREASED HIF-2α SIGNALING. Endocrine Practice. 22(2). 190–195. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact